Viewing Study NCT00492167


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-06-06 @ 9:05 PM
Study NCT ID: NCT00492167
Status: COMPLETED
Last Update Posted: 2022-03-07
First Post: 2007-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent neuroblastoma View
None regional neuroblastoma View
None stage 4S neuroblastoma View
None disseminated neuroblastoma View